These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19399901)

  • 21. Brain proteins that mind metals: a neurodegenerative perspective.
    Brown DR
    Dalton Trans; 2009 Jun; (21):4069-76. PubMed ID: 19452053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in the development of therapeutic antibodies targeting prion proteins and beta-amyloid peptides.
    He J; Zhang Y; Hong T
    Sci China Life Sci; 2010 Aug; 53(8):959-63. PubMed ID: 20821294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination for Parkinson's disease.
    Schneeberger A; Mandler M; Mattner F; Schmidt W
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S11-3. PubMed ID: 22166404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships.
    Bemporad F; Chiti F
    Chem Biol; 2012 Mar; 19(3):315-27. PubMed ID: 22444587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rapid dual staining procedure for the quantitative discrimination of prion amyloid from tissues reveals how interactions between amyloid and lipids in tissue homogenates may hinder the detection of prions.
    Hervé R; Collin R; Pinchin HE; Secker T; Keevil CW
    J Microbiol Methods; 2009 Apr; 77(1):90-7. PubMed ID: 19318058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected mice.
    Gourdain P; Grégoire S; Iken S; Bachy V; Dorban G; Chaigneau T; Debiec H; Bergot AS; Renault I; Aucouturier P; Carnaud C
    J Immunol; 2009 Nov; 183(10):6619-28. PubMed ID: 19846876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretase inhibitors and modulators for Alzheimer's disease treatment.
    Tomita T
    Expert Rev Neurother; 2009 May; 9(5):661-79. PubMed ID: 19402777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases.
    Coleman BM; Hill AF
    Semin Cell Dev Biol; 2015 Apr; 40():89-96. PubMed ID: 25704308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
    Fan J; Donkin J; Wellington C
    Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual aspects of neurologic protein misfolding disorders.
    Pula JH; Kim J; Nichols J
    Curr Opin Ophthalmol; 2009 Nov; 20(6):482-9. PubMed ID: 19816176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxysterols and neurodegenerative diseases.
    Björkhem I; Cedazo-Minguez A; Leoni V; Meaney S
    Mol Aspects Med; 2009 Jun; 30(3):171-9. PubMed ID: 19248803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.